SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about record date

18 Jun 2026 Evaluate
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to letter dated 18 June 2026 regarding the notice of 39th Annual General Meeting, Hester Biosciences has informed that the record date has been fixed Tuesday, 14 July 2026 to determine the members entitled for evoting at AGM and to receive the proposed final dividend of INR 11 per equity share (110% of the face value of INR 10 each), subject to declaration at the 39th Annual General Meeting and deduction of applicable tax.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

2076.80 23.15 (1.13%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: